Freestone Grove Partners’s uniQure QURE Stock Holding History

Freestone Grove Partners’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,984	Closed	-$311K	–	1145
2025 Q4	$311K	Buy	+12,984	New	+$501K	﹤0.01%	653

Other funds holding QURE

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Freestone Grove Partners's QURE Position: Q1 2026 in Review

Freestone Grove Partners sold out of uniQure (QURE) in Q1 2026, closing a stake of 12,984 shares — an estimated $311K sold.

Freestone Grove Partners first reported a position in QURE in Q4 2025 and held it in 1 quarter. The position peaked at $311K in Q4 2025. 214 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Freestone Grove Partners reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Freestone Grove Partners sold 12,984 uniQure shares in Q1 2026, an estimated $311K.
Freestone Grove Partners first reported a position in uniQure in Q4 2025 and held it in 1 quarter.
Freestone Grove Partners's uniQure position peaked at $311K in Q4 2025.
214 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.